2023
Hepatopancreatobiliary malignancies: time to treatment matters
Kerekes D, Frey A, Bakkila B, Johnson C, Becher R, Billingsley K, Khan S. Hepatopancreatobiliary malignancies: time to treatment matters. Journal Of Gastrointestinal Oncology 2023, 0: 0-0. PMID: 37201090, PMCID: PMC10186552, DOI: 10.21037/jgo-22-1067.Peer-Reviewed Original ResearchTreatment initiationStage IHPB cancersStage I pancreatic cancerExtrahepatic bile duct cancerKaplan-Meier survival analysisHPB cancer patientsNational Cancer DatabaseRetrospective cohort studyBile duct cancerMedian treatment initiationHepatopancreatobiliary cancersMedian survivalCohort studyDuct cancerOverall survivalHispanic patientsEHBD cancerOncologic careBile ductCox regressionBlack raceCancer patientsDefinitive carePancreatic cancer
2018
Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma
Blakaj A, Stein SM, Khan SA, Johung KL. Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma. Journal Of Gastrointestinal Oncology 2018, 9: 1027-1036. PMID: 30603121, PMCID: PMC6286948, DOI: 10.21037/jgo.2018.03.07.Peer-Reviewed Original ResearchStereotactic body radiation therapyManagement of LAPCRadiation therapyPancreatic cancerGood treatment tolerabilityProgressive local diseaseAdvanced pancreatic adenocarcinomaAdvanced pancreatic cancerEffective systemic therapyOverall poor prognosisBody radiation therapyTime of deathAreas of controversyTreatment tolerabilityLocal progressionSystemic regimensSurvival benefitSystemic therapyDose escalationImmune therapySignificant morbidityLocal diseasePoor prognosisOptimal treatmentPancreatic adenocarcinoma